$COR
Cencora, Inc. Stock $cor

$cor Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-Q Financial Statement

#000114085924000019 Filed on January 31, 2024

Income Statement

Concept	2024 Q1	2023 Q4
Revenue	$68.41B	$72.25B
YoY Change	7.81%	14.97%
Cost Of Revenue	$65.88B	$69.78B
YoY Change	7.71%	14.96%
Gross Profit	$2.538B	$2.469B
YoY Change	10.57%	15.05%
Gross Profit Margin	3.71%	3.42%
Selling, General & Admin	$1.389B	$1.399B
YoY Change	5.13%	8.35%
% of Gross Profit	54.72%	56.66%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$271.7M	$110.1M
YoY Change	11.02%	9.74%
% of Gross Profit	10.71%	4.46%
Operating Expenses	$1.661B	$1.399B
YoY Change	25.7%	8.35%
Operating Profit	$877.5M	$822.9M
YoY Change	56.55%	29.97%
Interest Expense	-$64.13M	-$40.56M
YoY Change	0.03%	-11.85%
% of Operating Profit	-7.31%	-4.93%
Other Income/Expense, Net	-$22.06M	$1.087M
YoY Change	-240.35%	-82.82%
Pretax Income	$467.1M	$783.4M
YoY Change	-8.8%	32.01%
Income Tax	$45.86M	$180.4M
% Of Pretax Income	9.82%	23.03%
Net Earnings	$420.8M	$601.5M
YoY Change	-3.36%	25.38%
Net Earnings / Revenue	0.62%	0.83%
Basic Earnings Per Share	$2.11	$3.01
Diluted Earnings Per Share	$2.09	$2.98
COMMON SHARES
Basic Shares Outstanding	199.5M shares	200.7M shares
Diluted Shares Outstanding	201.2M shares	201.8M shares

Balance Sheet

Concept	2024 Q1	2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$2.069B	$2.872B
YoY Change	34.39%	69.74%
Cash & Equivalents	$2.069B	$2.872B
Short-Term Investments
Other Short-Term Assets	$623.4M	$493.0M
YoY Change	27.75%	-75.28%
Inventory	$17.63B	$18.65B
Prepaid Expenses
Receivables	$23.84B	$21.58B
Other Receivables	$0.00	$21.59M
Total Short-Term Assets	$44.16B	$44.86B
YoY Change	10.43%	10.2%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.089B	$2.117B
YoY Change	-2.81%	-1.05%
Goodwill	$9.619B	$9.661B
YoY Change	-0.15%	12.37%
Intangibles	$4.176B	$4.376B
YoY Change	-14.52%	-1.21%
Long-Term Investments
YoY Change
Other Assets	$3.823B	$3.459B
YoY Change	103.38%	92.0%
Total Long-Term Assets	$19.71B	$19.83B
YoY Change	4.96%	15.31%
TOTAL ASSETS
Total Short-Term Assets	$44.16B	$44.86B
Total Long-Term Assets	$19.71B	$19.83B
Total Assets	$63.87B	$64.69B
YoY Change	8.68%	11.71%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$46.32B	$47.74B
YoY Change	8.39%	14.33%
Accrued Expenses	$2.372B	$2.437B
YoY Change	14.58%	20.99%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$1.069B	$592.8M
YoY Change	301.52%	-40.02%
Total Short-Term Liabilities	$49.76B	$50.77B
YoY Change	10.41%	13.43%
LONG-TERM LIABILITIES
Long-Term Debt	$4.180B	$4.186B
YoY Change	-10.42%	-10.1%
Other Long-Term Liabilities	$6.997B	$1.912B
YoY Change	563.08%	92.78%
Total Long-Term Liabilities	$11.18B	$6.098B
YoY Change	95.35%	7.97%
TOTAL LIABILITIES
Total Short-Term Liabilities	$49.76B	$50.77B
Total Long-Term Liabilities	$11.18B	$6.098B
Total Liabilities	$62.64B	$56.87B
YoY Change	23.33%	12.82%
SHAREHOLDERS EQUITY
Retained Earnings	$5.134B	$4.820B
YoY Change	39.08%	43.55%
Common Stock	$5.957B	$5.920B
YoY Change	3.18%	3.14%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.227B	$911.7M
YoY Change
Total Liabilities & Shareholders Equity	$63.87B	$64.69B
YoY Change	8.68%	11.71%

Cashflow Statement

Concept	2024 Q1	2023 Q4
OPERATING ACTIVITIES
Net Income	$420.8M	$601.5M
YoY Change	-3.36%	25.38%
Depreciation, Depletion And Amortization	$271.7M	$110.1M
YoY Change	11.02%	9.74%
Cash From Operating Activities	-$878.4M	$885.2M
YoY Change	-239.54%	24.66%
INVESTING ACTIVITIES
Capital Expenditures	$112.8M	$74.22M
YoY Change	9.62%	-1.99%
Acquisitions		$0.00
YoY Change
Other Investing Activities	-$53.73M	-$8.417M
YoY Change	-480.63%	212.55%
Cash From Investing Activities	-$166.5M	-$65.80M
YoY Change	87.62%	-95.65%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net		$83.64M
YoY Change		58.54%
Cash From Financing Activities	323.2M	-$551.7M
YoY Change	-142.0%	-42.77%
NET CHANGE
Cash From Operating Activities	-878.4M	$885.2M
Cash From Investing Activities	-166.5M	-$65.80M
Cash From Financing Activities	323.2M	-$551.7M
Net Change In Cash	-721.8M	$283.2M
YoY Change	215.63%	-116.85%
FREE CASH FLOW
Cash From Operating Activities	-$878.4M	$885.2M
Capital Expenditures	$112.8M	$74.22M
Free Cash Flow	-$991.2M	$810.9M
YoY Change	-288.21%	27.84%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q4	us-gaap	Profit Loss ProfitLoss	603008000	usd
CY2023Q4	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	69784021000	usd
CY2022Q4	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	60700879000	usd
CY2023Q4	us-gaap	Gross Profit GrossProfit	2468812000	usd
CY2022Q4	us-gaap	Gross Profit GrossProfit	2145953000	usd
CY2023Q4	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1398747000	usd
CY2022Q4	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1290928000	usd
CY2023Q4	us-gaap	Depreciation Nonproduction DepreciationNonproduction	104178000	usd
CY2022Q4	us-gaap	Depreciation Nonproduction DepreciationNonproduction	99542000	usd
CY2023Q4	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	166425000	usd
CY2022Q4	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	72398000	usd
CY2023Q4	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	-78917000	usd
CY2022Q4	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	12706000	usd
CY2023Q4	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	21063000	usd
CY2022Q4	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	20996000	usd
CY2023Q4	us-gaap	Restructuring Charges RestructuringCharges	34441000	usd
CY2022Q4	us-gaap	Restructuring Charges RestructuringCharges	16240000	usd
CY2023Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	822875000	usd
CY2022Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	633143000	usd
CY2023Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1087000	usd
CY2022Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	6328000	usd
CY2023Q4	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-40564000	usd
CY2022Q4	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-46016000	usd
CY2023Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	783398000	usd
CY2022Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	593455000	usd
CY2023Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	180390000	usd
CY2022Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	117285000	usd
CY2023Q4	us-gaap	Profit Loss ProfitLoss	603008000	usd
CY2022Q4	us-gaap	Profit Loss ProfitLoss	476170000	usd
CY2023Q4	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1508000	usd
CY2022Q4	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-3575000	usd
CY2023Q4	us-gaap	Net Income Loss NetIncomeLoss	601500000	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	479745000	usd
CY2023Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.01
CY2022Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.35
CY2023Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.98
CY2022Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.33
CY2023Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	200081000	shares
CY2022Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	204032000	shares
CY2023Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	201837000	shares
CY2022Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	206327000	shares
CY2023Q4	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.510
CY2022Q4	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.485
CY2023Q4	us-gaap	Profit Loss ProfitLoss	603008000	usd
CY2022Q4	us-gaap	Profit Loss ProfitLoss	476170000	usd
CY2023Q4	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	271522000	usd
CY2022Q4	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	396074000	usd
CY2023Q4	us-gaap	Other Comprehensive Income Other Net Of Tax OtherComprehensiveIncomeOtherNetOfTax	-88000	usd
CY2022Q4	us-gaap	Other Comprehensive Income Other Net Of Tax OtherComprehensiveIncomeOtherNetOfTax	-2709000	usd
CY2023Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	271434000	usd
CY2022Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	393365000	usd
CY2023Q4	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	874442000	usd
CY2022Q4	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	869535000	usd
CY2023Q4	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	6820000	usd
CY2022Q4	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-29262000	usd
CY2023Q4	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	867622000	usd
CY2022Q4	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	898797000	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	666287000	usd
CY2023Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	271434000	usd
CY2023Q4	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.510
CY2023Q4	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	105690000	usd
CY2023Q4	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	10926000	usd
CY2023Q4	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	63076000	usd
CY2023Q4	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	388473000	usd
CY2023Q4	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	56248000	usd
CY2023Q4	us-gaap	Stockholders Equity Other StockholdersEquityOther	3064000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1061256000	usd
CY2022Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	71273000	usd
CY2022Q4	us-gaap	Profit Loss ProfitLoss	476170000	usd
CY2022Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	393365000	usd
CY2022Q4	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.485
CY2022Q4	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	99713000	usd
CY2022Q4	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	21863000	usd
CY2022Q4	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	55633000	usd
CY2022Q4	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	778827000	usd
CY2022Q4	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	65217000	usd
CY2022Q4	us-gaap	Stockholders Equity Other StockholdersEquityOther	988000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	73559000	usd
CY2023Q4	us-gaap	Profit Loss ProfitLoss	603008000	usd
CY2022Q4	us-gaap	Profit Loss ProfitLoss	476170000	usd
CY2023Q4	us-gaap	Depreciation Depreciation	110109000	usd
CY2022Q4	us-gaap	Depreciation Depreciation	100332000	usd
CY2023Q4	us-gaap	Adjustment For Amortization AdjustmentForAmortization	168336000	usd
CY2022Q4	us-gaap	Adjustment For Amortization AdjustmentForAmortization	75080000	usd
CY2023Q4	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	15798000	usd
CY2022Q4	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-1486000	usd
CY2023Q4	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	3430000	usd
CY2022Q4	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-12326000	usd
CY2023Q4	us-gaap	Share Based Compensation ShareBasedCompensation	63076000	usd
CY2022Q4	us-gaap	Share Based Compensation ShareBasedCompensation	55633000	usd
CY2023Q4	us-gaap	Inventory Lifo Reserve Period Charge InventoryLIFOReservePeriodCharge	-48445000	usd
CY2022Q4	us-gaap	Inventory Lifo Reserve Period Charge InventoryLIFOReservePeriodCharge	25050000	usd
CY2023Q4	cor	Inflationary Accounting Impact InflationaryAccountingImpact	16919000	usd
CY2022Q4	cor	Inflationary Accounting Impact InflationaryAccountingImpact	3986000	usd
CY2023Q4	cor	Equity Investment Remeasurement Gain Loss EquityInvestmentRemeasurementGainLoss	-10201000	usd
CY2022Q4	cor	Equity Investment Remeasurement Gain Loss EquityInvestmentRemeasurementGainLoss	0	usd
CY2023Q4	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	2910000	usd
CY2022Q4	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	3322000	usd
CY2023Q4	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	504086000	usd
CY2022Q4	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	59872000	usd
CY2023Q4	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1095530000	usd
CY2022Q4	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1178035000	usd
CY2023Q4	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-55529000	usd
CY2022Q4	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-87394000	usd
CY2023Q4	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-16296000	usd
CY2022Q4	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	7421000	usd
CY2023Q4	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1765103000	usd
CY2022Q4	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1381079000	usd
CY2023Q4	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-238967000	usd
CY2022Q4	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-233640000	usd
CY2023Q4	cor	Increase Decrease In Income Taxes Payable And Other Liabilities IncreaseDecreaseInIncomeTaxesPayableAndOtherLiabilities	39464000	usd
CY2022Q4	cor	Increase Decrease In Income Taxes Payable And Other Liabilities IncreaseDecreaseInIncomeTaxesPayableAndOtherLiabilities	521000	usd
CY2023Q4	cor	Increase Decrease In Accrued Estimated Litigation Liability IncreaseDecreaseInAccruedEstimatedLitigationLiability	-92174000	usd
CY2022Q4	cor	Increase Decrease In Accrued Estimated Litigation Liability IncreaseDecreaseInAccruedEstimatedLitigationLiability	937000	usd
CY2023Q4	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	885157000	usd
CY2022Q4	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	710080000	usd
CY2023Q4	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	74217000	usd
CY2022Q4	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	75727000	usd
CY2023Q4	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	usd
CY2022Q4	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	1438124000	usd
CY2023Q4	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-8417000	usd
CY2022Q4	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-2693000	usd
CY2023Q4	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-65800000	usd
CY2022Q4	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1511158000	usd
CY2023Q4	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	90068000	usd
CY2022Q4	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	54960000	usd
CY2023Q4	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	83638000	usd
CY2022Q4	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	52756000	usd
CY2023Q4	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	11171677000	usd
CY2022Q4	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	1882229000	usd
CY2023Q4	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	11188576000	usd
CY2022Q4	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	1894951000	usd
CY2023Q4	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	385533000	usd
CY2022Q4	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	807214000	usd
CY2023Q4	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	10926000	usd
CY2022Q4	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	21863000	usd
CY2023Q4	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	105690000	usd
CY2022Q4	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	99713000	usd
CY2023Q4	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	56248000	usd
CY2022Q4	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	65217000	usd
CY2023Q4	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-4655000	usd
CY2022Q4	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-3145000	usd
CY2023Q4	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-551669000	usd
CY2022Q4	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-963944000	usd
CY2023Q4	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	15544000	usd
CY2022Q4	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	84140000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	283232000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1680882000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2752889000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3593539000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3036121000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1912657000	usd
CY2023Q4	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-bottom:8pt;margin-top:8pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect amounts reported in the financial statements and accompanying notes. Actual amounts could differ from these estimated amounts. Certain reclassifications have been made to prior-period amounts in order to conform to the current year presentation.</span></div>
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2872351000	usd
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2592051000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1692205000	usd
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3388189000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3036121000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2752889000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1912657000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3593539000	usd
CY2023Q1	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Deferred Tax Liabilities BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities	146000000	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	564900000	usd
CY2023Q4	cor	Unrecognized Tax Benefits Net Of Federal Benefit UnrecognizedTaxBenefitsNetOfFederalBenefit	491100000	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	475800000	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	28800000	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	13000000	usd
CY2023Q4	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.230
CY2022Q4	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.198
CY2023Q3	us-gaap	Goodwill Goodwill	9574117000	usd
CY2023Q4	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments	-12904000	usd
CY2023Q4	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	99329000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	9660542000	usd
CY2023Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	6220158000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1843727000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	4376431000	usd
CY2023Q3	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	6086886000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1655103000	usd
CY2023Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	4431783000	usd
CY2023Q4	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	166400000	usd
CY2022Q4	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	72400000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	675800000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	516100000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	356400000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	298900000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	288400000	usd
CY2023Q4	cor	Finite Lived Intangible Asset Expected Amortization After Year Four FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour	2390200000	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	4778723000	usd
CY2023Q3	us-gaap	Long Term Debt LongTermDebt	4787457000	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	4185944000	usd
CY2023Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	4146113000	usd
CY2023Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	200081000	shares
CY2022Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	204032000	shares
CY2023Q4	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1756000	shares
CY2022Q4	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	2295000	shares
CY2023Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	201837000	shares
CY2022Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	206327000	shares
CY2023Q4	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	320000	shares
CY2022Q4	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	370000	shares
CY2022Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	593455000	usd
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023Q4	us-gaap	Severance Costs1 SeveranceCosts1	11294000	usd
CY2022Q4	us-gaap	Severance Costs1 SeveranceCosts1	3320000	usd
CY2023Q4	cor	Business Transformation Efforts BusinessTransformationEfforts	24722000	usd
CY2022Q4	cor	Business Transformation Efforts BusinessTransformationEfforts	12920000	usd
CY2023Q4	us-gaap	Other Restructuring Costs OtherRestructuringCosts	-1575000	usd
CY2022Q4	us-gaap	Other Restructuring Costs OtherRestructuringCosts	0	usd
CY2023Q4	cor	Restructuring And Other Expenses RestructuringAndOtherExpenses	34441000	usd
CY2022Q4	cor	Restructuring And Other Expenses RestructuringAndOtherExpenses	16240000	usd
CY2023Q4	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	48200000	usd
CY2022Q4	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	49900000	usd
CY2023Q4	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
CY2023Q4	us-gaap	Revenues Revenues	72252833000	usd
CY2022Q4	us-gaap	Revenues Revenues	62846832000	usd
CY2023Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	822875000	usd
CY2022Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	633143000	usd
CY2023Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1087000	usd
CY2022Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	6328000	usd
CY2023Q4	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-40564000	usd
CY2022Q4	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-46016000	usd
CY2023Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	783398000	usd

Files In Submission

Name	View Source	Status
cor-20231231_cal.xml	Edgar Link	unprocessable
cor-20231231_lab.xml	Edgar Link	unprocessable
0001140859-24-000019-index-headers.html	Edgar Link	pending
0001140859-24-000019-index.html	Edgar Link	pending
0001140859-24-000019.txt	Edgar Link	pending
0001140859-24-000019-xbrl.zip	Edgar Link	pending
cor-20231231.htm	Edgar Link	pending
cor-20231231.xsd	Edgar Link	pending
cor-20231231_g1.gif	Edgar Link	pending
exhibit103-cencoradeferr.htm	Edgar Link	pending
exhibit103-cencoradeferr001.jpg	Edgar Link	pending
exhibit103-cencoradeferr002.jpg	Edgar Link	pending
exhibit103-cencoradeferr003.jpg	Edgar Link	pending
exhibit103-cencoradeferr004.jpg	Edgar Link	pending
exhibit103-cencoradeferr005.jpg	Edgar Link	pending
exhibit103-cencoradeferr006.jpg	Edgar Link	pending
exhibit103-cencoradeferr007.jpg	Edgar Link	pending
exhibit103-cencoradeferr008.jpg	Edgar Link	pending
exhibit103-cencoradeferr009.jpg	Edgar Link	pending
exhibit103-cencoradeferr010.jpg	Edgar Link	pending
exhibit103-cencoradeferr011.jpg	Edgar Link	pending
exhibit103-cencoradeferr012.jpg	Edgar Link	pending
exhibit103-cencoradeferr013.jpg	Edgar Link	pending
exhibit103-cencoradeferr014.jpg	Edgar Link	pending
exhibit103-cencoradeferr015.jpg	Edgar Link	pending
exhibit103-cencoradeferr016.jpg	Edgar Link	pending
exhibit103-cencoradeferr017.jpg	Edgar Link	pending
exhibit103-cencoradeferr018.jpg	Edgar Link	pending
exhibit103-cencoradeferr019.jpg	Edgar Link	pending
exhibit103-cencoradeferr020.jpg	Edgar Link	pending
exhibit103-cencoradeferr021.jpg	Edgar Link	pending
exhibit103-cencoradeferr022.jpg	Edgar Link	pending
exhibit311-q12024.htm	Edgar Link	pending
exhibit312-q12024.htm	Edgar Link	pending
exhibit32-q12024.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
cor-20231231_def.xml	Edgar Link	unprocessable
cor-20231231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
cor-20231231_htm.xml	Edgar Link	completed
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$COR
Cencora, Inc. Stock $cor

2024 Q1 Form 10-Q Financial Statement

#000114085924000019 Filed on January 31, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$COR Cencora, Inc. Stock $cor

2024 Q1 Form 10-Q Financial Statement

#000114085924000019 Filed on January 31, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$COR
Cencora, Inc. Stock $cor